Characterization of Human Brain Nicotinamide 5'-mononucleotide Adenylyltransferase-2 and Expression in Human Pancreas

Overview

Journal Biochem J

Specialty Biochemistry

Date 2003 Oct 1

PMID 14516279

Citations 25

Authors

Joel A Yalowitz

Suhong Xiao

Mangatt P Biju

Asok C Antony

Oscar W Cummings

Mark A Deeg

Hiremagalur N Jayaram

Affiliations

Soon will be listed here.

Abstract

NMNAT (nicotinamide 5'-mononucleotide adenylyltransferase; EC 2.7.7.1) catalyses the transfer of the adenylyl group from ATP to NMN to form NAD. We have cloned a novel human NMNAT cDNA, designated hNMNAT-2, from human brain. The cDNA contains a 924 bp open reading frame that encodes a 307 amino acid peptide that was expressed as a histidine-patch-containing thioredoxin fusion protein. Expressed hNMNAT-2 shared only 35% amino acid sequence homology with the human NMNAT enzyme (hNMNAT-1), but possessed enzymic activity comparable with hNMNAT-1. Using human genomic databases, hNMNAT-2 was localized to chromosome 1q25 within a 171 kb gene, whereas hNMNAT-1 is on chromosome 1p32-35. Northern blot analysis revealed highly restricted expression of hNMNAT-2 to brain, heart and muscle tissues, which contrasts with the wide tissue expression of hNMNAT-1; different regions of the brain exhibited differential expression of hNMNAT-2. Substitution mutations of either of two invariant residues, His-24 or Trp-92, abolished enzyme activity. Anti-peptide antibody to a unique epitope within hNMNAT-2 was produced, and immunohistochemical analysis of sections of normal adult human pancreas revealed that hNMNAT-2 protein was markedly expressed in the islets of Langerhans. However, the pancreatic exocrine cells exhibited weak expression of hNMNAT-2 protein. Sections of pancreas from insulinoma patients showed strong expression of hNMNAT-2 protein in the insulin-producing tumour cells, whereas acinar cells exhibited relatively low expression of hNMNAT-2 protein. These data suggest that the unique tissue-expression patterns of hNMNAT-2 reflect distinct functions for the isoforms in the regulation of NAD metabolism.

Citing Articles

NAD metabolism and heart failure: Mechanisms and therapeutic potentials.

Walker M, Tian R J Mol Cell Cardiol. 2024; 195:45-54.

PMID: 39096536 PMC: 11390314. DOI: 10.1016/j.yjmcc.2024.07.008.

Impact of NAD+ metabolism on ovarian aging.

Liang J, Huang F, Song Z, Tang R, Zhang P, Chen R Immun Ageing. 2023; 20(1):70.

PMID: 38041117 PMC: 10693113. DOI: 10.1186/s12979-023-00398-w.

Balancing NAD deficits with nicotinamide riboside: therapeutic possibilities and limitations.

Cercillieux A, Ciarlo E, Canto C Cell Mol Life Sci. 2022; 79(8):463.

PMID: 35918544 PMC: 9345839. DOI: 10.1007/s00018-022-04499-5.

Increased glycolysis affects β-cell function and identity in aging and diabetes.

Murao N, Yokoi N, Takahashi H, Hayami T, Minami Y, Seino S Mol Metab. 2021; 55:101414.

PMID: 34871777 PMC: 8732780. DOI: 10.1016/j.molmet.2021.101414.

The key role of the NAD biosynthetic enzyme nicotinamide mononucleotide adenylyltransferase in regulating cell functions.

Fortunato C, Mazzola F, Raffaelli N IUBMB Life. 2021; 74(7):562-572.

PMID: 34866305 PMC: 9299865. DOI: 10.1002/iub.2584.

References

Emanuelli M, Amici A, Carnevali F, Pierella F, Raffaelli N, Magni G . Identification and characterization of a second NMN adenylyltransferase gene in Saccharomyces cerevisiae. Protein Expr Purif. 2003; 27(2):357-64. DOI: 10.1016/s1046-5928(02)00645-9. View

Zhou T, Kurnasov O, Tomchick D, Binns D, Grishin N, Marquez V . Structure of human nicotinamide/nicotinic acid mononucleotide adenylyltransferase. Basis for the dual substrate specificity and activation of the oncolytic agent tiazofurin. J Biol Chem. 2002; 277(15):13148-54. DOI: 10.1074/jbc.M111469200. View

Bradford M . A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976; 72:248-54. DOI: 10.1016/0003-2697(76)90527-3. View

Cleland W . Statistical analysis of enzyme kinetic data. Methods Enzymol. 1979; 63:103-38. DOI: 10.1016/0076-6879(79)63008-2. View

Cooney D, Jayaram H, Gebeyehu G, Betts C, Kelley J, Marquez V . The conversion of 2-beta-D-ribofuranosylthiazole-4-carboxamide to an analogue of NAD with potent IMP dehydrogenase-inhibitory properties. Biochem Pharmacol. 1982; 31(11):2133-6. DOI: 10.1016/0006-2952(82)90436-1. View

Anderson B . Studies of NAD kinase and NMN:ATP adenylyltransferase in Haemophilus influenzae. J Gen Microbiol. 1990; 136(3):425-30. DOI: 10.1099/00221287-136-3-425. View

Kozak M . An analysis of vertebrate mRNA sequences: intimations of translational control. J Cell Biol. 1991; 115(4):887-903. PMC: 2289952. DOI: 10.1083/jcb.115.4.887. View

Jayaram H, Lapis E, Tricot G, Kneebone P, Paulik E, Zhen W . Clinical pharmacokinetic study of tiazofurin administered as a 1-hour infusion. Int J Cancer. 1992; 51(2):182-8. DOI: 10.1002/ijc.2910510204. View

Jayaram H, Zhen W, Gharehbaghi K . Biochemical consequences of resistance to tiazofurin in human myelogenous leukemic K562 cells. Cancer Res. 1993; 53(10 Suppl):2344-8. View

10.

Leslie R, Elliott R . Early environmental events as a cause of IDDM. Evidence and implications. Diabetes. 1994; 43(7):843-50. DOI: 10.2337/diab.43.7.843. View

11.

Adams M, Kerlavage A, Fleischmann R, Fuldner R, Bult C, Lee N . Initial assessment of human gene diversity and expression patterns based upon 83 million nucleotides of cDNA sequence. Nature. 1995; 377(6547 Suppl):3-174. View

12.

Balducci E, Emanuelli M, Raffaelli N, Ruggieri S, Amici A, Magni G . Assay methods for nicotinamide mononucleotide adenylyltransferase of wide applicability. Anal Biochem. 1995; 228(1):64-8. DOI: 10.1006/abio.1995.1315. View

13.

Altschul S, Madden T, Schaffer A, Zhang J, Zhang Z, Miller W . Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res. 1997; 25(17):3389-402. PMC: 146917. DOI: 10.1093/nar/25.17.3389. View

14.

Fisher C, Pei G . Modification of a PCR-based site-directed mutagenesis method. Biotechniques. 1997; 23(4):570-1, 574. DOI: 10.2144/97234bm01. View

15.

Seki N, Ohira M, Nagase T, Ishikawa K, Miyajima N, Nakajima D . Characterization of cDNA clones in size-fractionated cDNA libraries from human brain. DNA Res. 1998; 4(5):345-9. DOI: 10.1093/dnares/4.5.345. View

16.

Coleman M, Conforti L, Buckmaster E, Tarlton A, Ewing R, Brown M . An 85-kb tandem triplication in the slow Wallerian degeneration (Wlds) mouse. Proc Natl Acad Sci U S A. 1998; 95(17):9985-90. PMC: 21448. DOI: 10.1073/pnas.95.17.9985. View

17.

Li G, Segu V, Rabaglia M, Luo R, Kowluru A, Metz S . Prolonged depletion of guanosine triphosphate induces death of insulin-secreting cells by apoptosis. Endocrinology. 1998; 139(9):3752-62. DOI: 10.1210/endo.139.9.6207. View

18.

Raffaelli N, Lorenzi T, Amici A, Emanuelli M, Ruggieri S, Magni G . Synechocystis sp. slr0787 protein is a novel bifunctional enzyme endowed with both nicotinamide mononucleotide adenylyltransferase and 'Nudix' hydrolase activities. FEBS Lett. 1999; 444(2-3):222-6. DOI: 10.1016/s0014-5793(99)00068-x. View

19.

Masutani M, Suzuki H, Kamada N, Watanabe M, Ueda O, Nozaki T . Poly(ADP-ribose) polymerase gene disruption conferred mice resistant to streptozotocin-induced diabetes. Proc Natl Acad Sci U S A. 1999; 96(5):2301-4. PMC: 26778. DOI: 10.1073/pnas.96.5.2301. View

20.

Raffaelli N, Emanuelli M, Pisani F, Amici A, Lorenzi T, Ruggieri S . Identification of the archaeal NMN adenylytransferase gene. Mol Cell Biochem. 1999; 193(1-2):99-102. View